Table: begin end state 1 25 signal peptide 26 33 non-cytoplasmic 34 55 transmembrane 56 61 cytoplasmic 62 80 transmembrane 81 85 non-cytoplasmic 86 107 transmembrane 108 113 cytoplasmic 114 132 transmembrane 133 161 non-cytoplasmic 162 181 transmembrane 182 206 cytoplasmic 207 228 transmembrane 229 247 non-cytoplasmic 248 273 transmembrane 274 289 cytoplasmic 290 308 transmembrane 309 594 non-cytoplasmic
Input: >WP_012402388.1 NCBI__GCF_000020045.1:WP_012402388.1 MNRIMKNKLFWLFLVVMFALPVLPQPIRVPEYWVTLLNYIGLYSIVAIGLVLLTGIGGMT SFGQAAFVGVGAYTTAYLTTQLGVSPWLALIAGVVLTALIALLLGAVTMRLSGHFLPLGT IAWGLALFFLFGNMEMLGKYDGINGIPVLNVLGVNLESGRHIYYLIWIVVLGAVVSVQNL LNSRPGRAIRALRGGGLMAEAMGVNTAWMRVVIFVYAAVLAAISGFLYAHLQRAVNPTPF GLNHGIEFLFMAVVGGVAHVWGAVLGAAILTVLQDYLQTLLPKLLGENGNFEIIVFGILM VLLLQYARQGVWPFVARSFPRGPRAHVPDHADALPQRSKPATGEPLLVVDKARKQFGGLV AVNDVSFEVKAGQIIGLIGPNGAGKSTTFNLVTGVLQATSGAITFRGERIDALNSREIVK RGIGRTFQHVKLLPGMTVLENVAIGGHLRGRAGVWRSVARLNGAEEGRLMAEAARQIRRV GLEEHMYDEAGSLALGKQRILEIARALCCDPTLLLLDEPAAGLRYQEKQQLATLLRKLRE EGMSLLLVEHDMDFVMNLTDRLVVMEFGTRIAEGLPQDVQNDPAVLEAYLGGVE
Or try the official Phobius web server, which has a different display
Reference: Advantages of combined transmembrane topology and signal peptide prediction - the Phobius web server